Covalent targeted radioligands potentiate radionuclide therapy

Cancer statistics, 2023

Rebecca L. Siegel, Kimberly D. Miller, Nikita Sandeep Wagle et al. · CA A Cancer Journal for Clinicians · 2023 · 16.7K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Phase 3 Trial of ¹⁷⁷ Lu-Dotatate for Midgut Neuroendocrine Tumors

Jonathan Strosberg, Ghassan El‐Haddad, Edward M. Wolin et al. · New England Journal of Medicine · 2017 · 3.2K citations · Full text

Medicine, Oncology, Pharmacology +17

Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer

Oliver Sartor, Johann S. de Bono, Kim N. et al. · New England Journal of Medicine · 2021 · 2.6K citations · Full text

Medicine, Oncology, Radiation Oncology +17

⁶⁸Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer

Clemens Kratochwil, Paul Flechsig, Thomas Lindner et al. · Journal of Nuclear Medicine · 2019 · 1.4K citations · Full text

Medicine, Nuclear Medicine, Oncology +17

OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine.

Michael G. Stabin, Richard Sparks, Eric A. Crowe · PubMed · 2005 · 1.4K citations

Medicine, Internal Medicine, Nuclear Medicine +14